Elizabeth Moore

Second year student at CRUK CI

The majority of women with ovarian cancer have widespread disease at diagnosis, fewer than 20% will survive 5 years. Conversely over 90% of women with localised disease will survive over 5 years. New diagnostic biomarkers enabling earlier detection are urgently needed. I have developed sensitive molecular profiling methods to detect tumour DNA in blood from women with newly diagnosed, including localised, ovarian cancer. I am establishing a clinical study with large cohorts of symptomatic women. If sensitivity and specificity are promising these methods could be transferred to primary care to triage symptomatic women, leading to earlier diagnosis and saving lives.

Other 2018 award winners

Tiesheng Wang

Luca Peruzzotti-Jametti

Jan Lyczakowski

Craig Pearson

Taherzadeh Oliver

Alexander Avramenko

Vera Graup

Chen Jiang

Joachim Dias

Previous award winners

Find out about the winners awarded in previous years: